About Us
Clinicians
Services
Test Information
New Testing Developments
Laboratory Supplies
Directory of Client Services
Customer Service
Other Resources
Patients
Clinical Trials
Careers
Employees
 
  Highlights

Important Notices
Patient Services Centre Locator
Clinician Satisfaction Survey
Sign Up for Updates

 
Important Notices

 

Listeria Monocytogenes Testing - Specimen Collection
August 29, 2008: Gamma-Dynacare is requesting the assistance of clinicians in helping to ensure that patients showing symptoms of listeriosis are appropriately tested.

Gamma-Dynacare Offers the Only FDA-Approved HPV Screening Test
December 1, 2007: Gamma-Dynacare Medical Laboratories offers an advanced technology and the ONLY FDA-approved adjunctive screening test available.

Gamma-Dynacare Expands Its Trace Metals Testing
December 1, 2007: Gamma-Dynacare Medical Laboratories has recently expanded its trace metal testing platform utilizing the latest technology used for trace metal detection, identification and quantification.

ColonCancerCheck: Improving Specimen Acceptability
July 4, 2008: Gamma-Dynacare is requesting the assistance of clinicians in helping to improve the rate of Fecal Occult Blood Test (FOBT) specimen acceptability.

Chlamydia Trachomatis - Upgraded Testing Methodology
July 4, 2008: Gamma-Dynacare has upgraded our Chlamydia trachomatis testing methodology to an advanced Gen-Probe Nucleic Acid Transcription Mediated Amplification (TMA) assay with superior sensitivity and specificity.

Serum Free Light Chain Analysis
September 10, 2008: With the recent addition of Freelite to our test menu, Gamma-Dynacare is pleased to ofer serum Free Light Chain (FLC) analysis as a further aid in the diagnosis and monitoring of monoclonal gammopathies.

Electronic Cytology Requisition Form
October 6, 2008: Gamma-Dynacare is pleased to introduce a new cytology requisition form that physicians and clients can download and complete electronically.

Electronic Histology Requisition Form
October 20, 2008: Gamma-Dynacare is pleased to introduce a new histology requisition form that physicians and clients can download and complete electronically.

Gamma-Dynacare Named One of Canada's Top 100 Employers
October 23, 2008: Gamma-Dynacare has been named one of Canada's Top 100 Employers for 2009 and one of the Greater Toronto Area's Top 75 Employers by Mediacorp Canada Inc.

Gamma-Dynacare To Acquire Central Medical Laboratories
November 28, 2008: Gamma-Dynacare has entered into a definitive agreement to acquire Central Medical Laboratories, Manitoba's largest provider of community laboratory services.

Swine Influenza Update
April 30, 2009: The Ontario Ministry of Health and Long-Term Care issued updated guidance today regarding laboratory testing for swine influenza A.

Manitoba A/H1N1 Influenza Update
May 6, 2009: Manitoba Health has developed a document that provides interim guidance for clinicians in ambulatory settings regarding laboratory testing for Novel A/H1N1 Influenza.

Requisitions for Ordering Supplies
June 9, 2009: Gamma-Dynacare provides supplies required by our regular clients for the collection of specimens.

Urine Specimen Container Recall
June 11, 2009: Gamma-Dynacare is requesting the assistance of clinicians in returning supplies of 90 ml urine specimen containers, as we are experiencing a leakage issue with a large number of these containers.

Ordering FOBT and Stool O/B Kits
June 15, 2009: Gamma-Dynacare is pleased to provide information to assist clinicians in ordering supplies of Fecal Occult Blood Test kits under the Ontario ColonCancerCheck screening program.

HPV DNA Testing
June 22, 2009: Human Papillomavirus (HPV) is now well established as the major etiologic agent for cervical cancer and its precursors. Studies demonstrate high-risk HPV types are found in more than 99.7% of cervical cancer cases.

Physician Order Forms - ColonCancerCheck FOBT kits
April 1, 2008: Gamma-Dynacare is pleased to participate in the new ColonCancerCheck program launched by the Ontario Ministry of Health and Long-Term Care and Cancer Care Ontario.

Pharmacist Order Forms - ColonCancerCheck FOBT kits
April 1, 2008: Gamma-Dynacare is pleased to participate in the new ColonCancerCheck program launched in Ontario by the Ministry of Health and Long-Term Care and Cancer Care Ontario.

PSA Insured Testing
January 9, 2009: The Ontario Ministry of Health and Long-Term Care is implementing a new policy to improve patient access through community laboratories to Prostate-Specific Antigen (PSA) testing.

Quebec A/H1N1 Influenza Update
May 6, 2009: The Quebec Public Health Laboratory has issued guidance regarding reporting and laboratory testing for A/H1N1 influenza.

Procedures for Referred CT/GC Testing
June 23, 2009: Gamma-Dynacare is currently validating the implementation of an upgraded testing methodology that offers testing for Chlamydia trachomatis (CT) as well as Neisseria gonorrhoeae (GC) on the same specimen.

Automated Cervical Cytology Screening
June 29, 2009: Gamma-Dynacare is pleased to introduce BD FocalPoint Slide Profiler Intelligent Pap Imaging systems into our Ontario cytology laboratories.

Routine Testing for Urogenital Syndromes
August 5, 2009: Beginning August 8, 2009, Gamma-Dynacare will test for Chlamydia trachomatis and Neisseria gonorrhoeae with one sample, either GenProbe Unisex swab or urine.

Shortage of Glucose Tolerance Test Beverage
September 23, 2009: Gamma-Dynacare wishes to inform clinicians of a current national shortage of the Trutol Glucose Tolerance Test Beverage, 50 grams and 75 grams.

Thyroglobulin
November 20, 2009: Due to issues relating to a change in reagent lot, Gamma-Dynacare has temporarily suspended in-house testing of thyroglobulin and is sending samples to a reference laboratory.

New OAML Guideline for Phoning of Critical Results
December 1, 2009: The Ontario Association of Medical Laboratories recently amended its Guideline for Reporting Laboratory Test Results.

Urine Preservative Tube Required for Microscopic Analysis
June 22, 2009: Effective July 1, 2009, all urine microscopic analyses must be submitted in a urine preservative tube.

MRSA and VRE: Inapprropriate Surveillance Sampling
December 2, 2009: The importance of methicillin-resistant Staphylococcus aureus (MRSA) and Vancomycin-resistant Enterococcus (VRE) testing is now universally accepted with established collection and testing procedures.



 
 
contact us